According to The Insight Partners market research study on "Bioreactors Market to 2027 – Global Analysis and Forecasts by Cell, Molecule, Technology, and End User". The global bioreactors market is expected to reach US$ 5,169.01 Mn by 2027 from US$ 2,958.50 Mn in 2019. The market is estimated to grow at a CAGR of 7.3% from 2020 to 2027. The report provides trends prevailing in the global bioreactors market and the factors driving or restraining the market growth.
A bioreactor is a device or system engineered or manufactured to support biologically active environment. These are vessels in which a chemical processes involving organisms or biochemically active substances derived from such organisms are carried out. The increasing adoption of single-use bioreactors, and rapid growth of the pharmaceuticals and biotechnology industries are among the prime factors driving the bioreactors market. Additionally, increasing number of technology and distribution collaborations is anticipated to drive the market growth in the coming years. However, stringent government regulations hamper the growth of the market. The developing healthcare infrastructure and increasing investments by biopharmaceutical companies are projected generate lucrative opportunities for the growth of the market.
Rapid Growth of Pharmaceuticals and Biotechnology Industries
In recent years, the pharmaceutical industry has been growing at an unprecedented pace. Big pharmaceutical companies and contract research organizations (CROs) are coming up with new medicines and therapy forms to treat a wide range of indications.
The biopharmaceuticals market is increasing. The strong demand for biologics and bio similar has driven the growth of the industry. The biopharmaceutical industry is one of the most significant contributors to the economy. The US is the largest market for biopharmaceuticals and leader in biopharmaceutical R&D. As per the Pharmaceutical Research and Manufacturers Association (PhRMA), the US firms conduct over half the world's R&D in pharmaceuticals (US$ 75 billion) and hold the highest number of patents in new medicines. Besides development economies, there have been rapid growth witnesses in the research environment in emerging economies such as Brazil, China, and India. Factors such as increasing biologics approval, growing bio similar pipeline, and increasing investment in research activities are prime factors facilitating the growth of the industry.
Moreover, biopharmaceutical research activities are gaining pace in emerging economies such as Brazil, China, and India, and offering lucrative opportunities for the growth of the market. Apart from this, increasing approvals in gene and cell therapies are favoring the growth of the market. The approved gene therapies are Glybera-used to treat Lipoprotein Lipase Deficiency, and Strimvelis- treating ADA-Severe Combined Immuno Deficiency.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek